Stocks and Investing Stocks and Investing
Tue, August 27, 2024
Mon, August 26, 2024

Francois Brisebois Reiterated (TRDA) at Buy and Held Target at $25 on, Aug 26th, 2024


Published on 2024-10-28 13:53:51 - WOPRAI, Francois Brisebois
  Print publication without navigation


Francois Brisebois of Oppenheimer, Reiterated "Entrada Therapeutics, Inc." (TRDA) at Buy and Held Target at $25 on, Aug 26th, 2024.

Francois has made no other calls on TRDA in the last 4 months.



There is 1 other peer that has a rating on TRDA. Out of the 1 peers that are also analyzing TRDA, 0 agree with Francois's Rating of Hold.



This is the rating of the analyst that currently disagrees with Francois


  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $18 on, Wednesday, August 14th, 2024
Contributing Sources